Click for best price
Biopharmaceutical Vaccine Market Size, Share 2023
| Market size in 2022 |
US$ 407.72 billion
|
Forecast Market size by 2029 |
US$ 651.58 billion
|
| Growth Rate |
CAGR of 8.03% |
Number of Pages |
61 Pages |
Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccine Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccine Production. This report contains market size and forecasts of Biopharmaceutical and Vaccine Production in global, including the following market information:
Global top five companies in 2022 (%)
The global Biopharmaceutical and Vaccine Production market was valued at US$ 407.72 billion in 2022 and is projected to reach US$ 651.58 billion by 2029, at a CAGR of 8.03% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biopharmaceutical Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical and Vaccine Production include Novartis, Pfizer, Sanofi, Roche, Abbott, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson and GlaxoSmithKline, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceutical and Vaccine Production companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical and Vaccine Production Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceutical and Vaccine Production Market Segment Percentages, by Type, 2022 (%)
- Biopharmaceutical
- Vaccine Production
Global Biopharmaceutical and Vaccine Production Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceutical and Vaccine Production Market Segment Percentages, by Application, 2022 (%)
- Pharmaceutical
- Biotechnology
- Academic and Research Institutes
- Others
Global Biopharmaceutical and Vaccine Production Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biopharmaceutical and Vaccine Production Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biopharmaceutical and Vaccine Production revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Biopharmaceutical and Vaccine Production revenues share in global market, 2022 (%)
Key players include:
- Novartis
- Pfizer
- Sanofi
- Roche
- Abbott
- Regeneron Pharmaceuticals
- Alexion Pharmaceuticals
- Johnson and Johnson
- GlaxoSmithKline
- Merck
- Lonza
- FUJIFILM Diosynth Biotechnologies
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biopharmaceutical and Vaccine Production, market overview.
- Chapter 2: Global Biopharmaceutical and Vaccine Production market size in revenue.
- Chapter 3: Detailed analysis of Biopharmaceutical and Vaccine Production company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biopharmaceutical and Vaccine Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biopharmaceutical and Vaccine Production Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 407.72 billion
|
| Forecast Market size by 2029 |
US$ 651.58 billion
|
| Growth Rate |
CAGR of 8.03% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biopharmaceutical and Vaccine Production Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biopharmaceutical and Vaccine Production Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biopharmaceutical and Vaccine Production Overall Market Size
2.1 Global Biopharmaceutical and Vaccine Production Market Size: 2022 VS 2029
2.2 Global Biopharmaceutical and Vaccine Production Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biopharmaceutical and Vaccine Production Players in Global Market
3.2 Top Global Biopharmaceutical and Vaccine Production Companies Ranked by Revenue
3.3 Global Biopharmaceutical and Vaccine Production Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceutical and Vaccine Production Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biopharmaceutical and Vaccine Production Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceutical and Vaccine Production Players in Global Market
3.6.1 List of Global Tier 1 Biopharmaceutical and Vaccine Production Companies
3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceutical and Vaccine Production Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biopharmaceutical and Vaccine Production Market Size Markets, 2022 & 2029
4.1.2 Biopharmaceutical
4.1.3 Vaccine Production
4.2 By Type - Global Biopharmaceutical and Vaccine Production Revenue & Forecasts
4.2.1 By Type - Global Biopharmaceutical and Vaccine Production Revenue, 2018-2023
4.2.2 By Type - Global Biopharmaceutical and Vaccine Production Revenue, 2024-2029
4.2.3 By Type - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biopharmaceutical and Vaccine Production Market Size, 2022 & 2029
5.1.2 Pharmaceutical
5.1.3 Biotechnology
5.1.4 Academic and Research Institutes
5.1.5 Others
5.2 By Application - Global Biopharmaceutical and Vaccine Production Revenue & Forecasts
5.2.1 By Application - Global Biopharmaceutical and Vaccine Production Revenue, 2018-2023
5.2.2 By Application - Global Biopharmaceutical and Vaccine Production Revenue, 2024-2029
5.2.3 By Application - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biopharmaceutical and Vaccine Production Market Size, 2022 & 2029
6.2 By Region - Global Biopharmaceutical and Vaccine Production Revenue & Forecasts
6.2.1 By Region - Global Biopharmaceutical and Vaccine Production Revenue, 2018-2023
6.2.2 By Region - Global Biopharmaceutical and Vaccine Production Revenue, 2024-2029
6.2.3 By Region - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biopharmaceutical and Vaccine Production Revenue, 2018-2029
6.3.2 US Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.3.3 Canada Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.3.4 Mexico Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biopharmaceutical and Vaccine Production Revenue, 2018-2029
6.4.2 Germany Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.4.3 France Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.4.4 U.K. Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.4.5 Italy Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.4.6 Russia Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.4.7 Nordic Countries Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.4.8 Benelux Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biopharmaceutical and Vaccine Production Revenue, 2018-2029
6.5.2 China Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.5.3 Japan Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.5.4 South Korea Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.5.5 Southeast Asia Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.5.6 India Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biopharmaceutical and Vaccine Production Revenue, 2018-2029
6.6.2 Brazil Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.6.3 Argentina Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biopharmaceutical and Vaccine Production Revenue, 2018-2029
6.7.2 Turkey Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.7.3 Israel Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.7.4 Saudi Arabia Biopharmaceutical and Vaccine Production Market Size, 2018-2029
6.7.5 UAE Biopharmaceutical and Vaccine Production Market Size, 2018-2029
7 Biopharmaceutical and Vaccine Production Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Biopharmaceutical and Vaccine Production Major Product Offerings
7.1.4 Novartis Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Biopharmaceutical and Vaccine Production Major Product Offerings
7.2.4 Pfizer Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Biopharmaceutical and Vaccine Production Major Product Offerings
7.3.4 Sanofi Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Biopharmaceutical and Vaccine Production Major Product Offerings
7.4.4 Roche Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Biopharmaceutical and Vaccine Production Major Product Offerings
7.5.4 Abbott Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 Regeneron Pharmaceuticals
7.6.1 Regeneron Pharmaceuticals Company Summary
7.6.2 Regeneron Pharmaceuticals Business Overview
7.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Major Product Offerings
7.6.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.6.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Company Summary
7.7.2 Alexion Pharmaceuticals Business Overview
7.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Major Product Offerings
7.7.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.7.5 Alexion Pharmaceuticals Key News & Latest Developments
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Company Summary
7.8.2 Johnson and Johnson Business Overview
7.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Major Product Offerings
7.8.4 Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.8.5 Johnson and Johnson Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Major Product Offerings
7.9.4 GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biopharmaceutical and Vaccine Production Major Product Offerings
7.10.4 Merck Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 Lonza
7.11.1 Lonza Company Summary
7.11.2 Lonza Business Overview
7.11.3 Lonza Biopharmaceutical and Vaccine Production Major Product Offerings
7.11.4 Lonza Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.11.5 Lonza Key News & Latest Developments
7.12 FUJIFILM Diosynth Biotechnologies
7.12.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Major Product Offerings
7.12.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue in Global Market (2018-2023)
7.12.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biopharmaceutical and Vaccine Production Market Opportunities & Trends in Global Market
Table 2. Biopharmaceutical and Vaccine Production Market Drivers in Global Market
Table 3. Biopharmaceutical and Vaccine Production Market Restraints in Global Market
Table 4. Key Players of Biopharmaceutical and Vaccine Production in Global Market
Table 5. Top Biopharmaceutical and Vaccine Production Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Biopharmaceutical and Vaccine Production Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Biopharmaceutical and Vaccine Production Revenue Share by Companies, 2018-2023
Table 8. Global Companies Biopharmaceutical and Vaccine Production Product Type
Table 9. List of Global Tier 1 Biopharmaceutical and Vaccine Production Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceutical and Vaccine Production Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Biopharmaceutical and Vaccine Production Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Biopharmaceutical and Vaccine Production Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Biopharmaceutical and Vaccine Production Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Biopharmaceutical and Vaccine Production Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Biopharmaceutical and Vaccine Production Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Biopharmaceutical and Vaccine Production Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Biopharmaceutical and Vaccine Production Product Offerings
Table 32. Novartis Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Biopharmaceutical and Vaccine Production Product Offerings
Table 36. Pfizer Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Biopharmaceutical and Vaccine Production Product Offerings
Table 40. Sanofi Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Biopharmaceutical and Vaccine Production Product Offerings
Table 44. Roche Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Abbott Company Summary
Table 47. Abbott Biopharmaceutical and Vaccine Production Product Offerings
Table 48. Abbott Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. Regeneron Pharmaceuticals Company Summary
Table 51. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product Offerings
Table 52. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 53. Regeneron Pharmaceuticals Key News & Latest Developments
Table 54. Alexion Pharmaceuticals Company Summary
Table 55. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product Offerings
Table 56. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 57. Alexion Pharmaceuticals Key News & Latest Developments
Table 58. Johnson and Johnson Company Summary
Table 59. Johnson and Johnson Biopharmaceutical and Vaccine Production Product Offerings
Table 60. Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson and Johnson Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product Offerings
Table 64. GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Biopharmaceutical and Vaccine Production Product Offerings
Table 68. Merck Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 69. Merck Key News & Latest Developments
Table 70. Lonza Company Summary
Table 71. Lonza Biopharmaceutical and Vaccine Production Product Offerings
Table 72. Lonza Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 73. Lonza Key News & Latest Developments
Table 74. FUJIFILM Diosynth Biotechnologies Company Summary
Table 75. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product Offerings
Table 76. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue (US$, Mn) & (2018-2023)
Table 77. FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
List of Figures
Figure 1. Biopharmaceutical and Vaccine Production Segment by Type in 2022
Figure 2. Biopharmaceutical and Vaccine Production Segment by Application in 2022
Figure 3. Global Biopharmaceutical and Vaccine Production Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biopharmaceutical and Vaccine Production Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biopharmaceutical and Vaccine Production Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2022
Figure 8. By Type - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 9. By Application - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 10. By Type - Global Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 12. By Application - Global Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 14. By Region - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 15. By Country - North America Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 16. US Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 20. Germany Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 21. France Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 28. China Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 32. India Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 34. Brazil Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Biopharmaceutical and Vaccine Production Revenue Market Share, 2018-2029
Figure 37. Turkey Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Lonza Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
